ASAQ Launch

[ March 2007 ]
Sanofi-aventis and DNDi launched ASAQ, the new fixed-dose combination of artesunate (AS) and amodiaquine (AQ), which is now available in 21 countries throughout sub-Saharan Africa (June 08). ASAQ, the first drug developed by DNDi, is an innovative product to treat malaria that is adapted to the needs of patients of all ages, simple to use, accessible as a non patented drug, and available at an affordable price.

Second DNDi Africa Meeting

[ September 2006 ]
Nairobi, Kenya
Over 200 African scientists from 34 countries met in Nairobi, Kenya, 19-23 September at an international conference organised by the Drugs for Neglected Diseases initiative (DNDi), to explore developing greater regional research partnerships to combat the most neglected diseases, such as sleeping sickness, kala azar and malaria.


 6-11 August 2006 ]
Glasgow, Scotland

11th International Congress of Parasitology.


[27 July 2004]
Nairobi, Kenya

Workshop organized to discuss the collaboration of international initiatives involved in interventions for Poverty Related Diseases.